Predictive factors of toxicity of immune checkpoint inhibitors (ICI) in older patients with lung cancer: The ToxImmune study.

被引：0
|
作者：
Helissey, Carole
Difoum, Francoise
Vanquaethem, Helene
Vuagnat, Perrine
Picchi, Hugo
Le Roy, Audrey
Schernberg, Antoine
机构：
[1] Mil Hosp Begin, Clin Res Unit, St Mande, France
[2] Mil Hosp Begin, St Mande, France
[3] Hop Instruct Armees Begin, St Mande, France
[4] Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France
[5] Mil Hosp Begin, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12048
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Outcomes with Immune Checkpoint Inhibitors (ICI) for Relapsed Small Cell Lung Cancer (SCLC) in a Swiss Cohort
    Mauti, L.
    Schmid, S.
    Demmer, I.
    Friedlaender, A.
    Blum, V.
    Rothschild, S.
    Bouchaab, H.
    Froesch, P.
    Britschgi, C.
    Koenig, D.
    Wannesson, L.
    Janthur, W.
    Schaer, S.
    Addeo, A.
    Jochum, W.
    Fruh, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S821 - S822
  • [32] Lung cancer, elderly and immune checkpoint inhibitors
    Casaluce, Francesca
    Sgambato, Assunta
    Maione, Paolo
    Spagnuolo, Alessia
    Gridelli, Cesare
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1474 - S1481
  • [33] Using Immune Checkpoint Inhibitors in Lung Cancer
    Marrone, Kristen A.
    Brahmer, Julie R.
    ONCOLOGY-NEW YORK, 2016, 30 (08): : 713 - 721
  • [34] Update on Immune Checkpoint Inhibitors in Lung Cancer
    Creelan, Benjamin C.
    CANCER CONTROL, 2014, 21 (01) : 80 - 89
  • [35] Immune Checkpoint Inhibitors in Lung Cancer and Melanoma
    Madden, Kathleen
    Kasler, Mary Kate
    SEMINARS IN ONCOLOGY NURSING, 2019, 35 (05)
  • [36] Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitors: Antibiotics immune checkpoint inhibitors in advanced NSCLC
    Schett, Anne
    Rothschild, Sacha I.
    Curioni-Fontecedro, Alessandra
    Kraehenbuehl, Stephan
    Frueh, Martin
    Schmid, S.
    Driessen, Christoph
    Joerger, Markus
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (01) : 121 - 131
  • [37] Clinical features of immune checkpoint inhibitor-related pneumonitis in older patients with lung cancer receiving immune checkpoint inhibitors-based therapy: a retrospective study
    Jiafan Liu
    Dongmei Zhou
    Na Wu
    Jia Liu
    Xiaonan Wang
    BMC Geriatrics, 25 (1)
  • [38] Immune checkpoint inhibitors in lung cancer: an update
    Sullivan, Kevin
    Preeshagul, Isabel
    Budman, Daniel
    Seetharamu, Nagashree
    FUTURE ONCOLOGY, 2017, 13 (11) : 955 - 959
  • [39] Prospective observational study of nutritional and immunological indices as predictive biomarkers of response to immune checkpoint inhibitors in non-small cell lung cancer (ICI-PREDICT study)
    Takamori, Shinkichi
    Shimokawa, Mototsugu
    Yamaguchi, Masafumi
    Mori, Masahide
    Kuyama, Shoichi
    Oki, Masahide
    Nishimura, Yoshifumi
    Nakatomi, Katsumi
    Yanai, Hidetoshi
    Sukoh, Noriaki
    Hatakeyama, Nobuo
    Kita, Toshiyuki
    Fujiwara, Keiichi
    Chibana, Kenji
    Okamoto, Masaki
    Takenoyama, Mitsuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Ushio, Ryota
    Murakami, Shuji
    Saito, Haruhiro
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
12345